AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2015
Feb 13, 2015
34301_dirs_2015-02-13_3c0ee41b-5246-428e-a4a3-d743ce8aad3a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-02-13
Reporting Person: Hawkins Richard J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-13 | Incentive Stock Option (Right to Buy) | $0.47 | A | 25000 | Acquired | 2025-02-13 | Common Stock (25000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 41926 | Direct |
Footnotes
F1: The stock options vest 1/12th each month from date of grant, subject to the terms of the Company's 2014 Equity Incentive Plan.
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
Jun 18
Capital/Financing Update
2026
Jun 5
Regulatory Filings
2026
Jun 5
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Call Transcript
2026
May 14
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9